BALTIMORE, Jan. 24, 2018 – Elixirgen Scientific’s new kit option for Quick-Neuron™ Cholinergic enables high throughput screening for drug discovery and toxicity screening. The new option is called the Quick-Neuron™ Cholinergic – SeV Complete Kit (for a 96-well microplate format). The Baltimore biotech company today released Quick-Neuron™ Cholinergic – SeV Complete Kit (for a 96-well microplate format) to add to its current Quick-Neuron™ Cholinergic product lineups. This new option will help scientists create cholinergic neurons in only 6 to 11 days from their pluripotent stem cells. The new option to receive differentiating cholinergic neurons on a 96-well microplate format is also available through Elixirgen Scientific’s cell differentiation services.
The kit is a part of the Quick-Tissue™ Series – a revolutionary new way to generate human cells, tissues, and organs. The Quick-Tissue™ Series kits’ potent cocktails of transcription factors transform researchers’ stem cells of choice into high-quality and homogeneous tissues in a scalable, speedy manner. The addition of the 96-well microplate format will provide direct access to an off-the-shelf product for high throughput screening of a collection of compounds for drug discovery and toxicity screening.